Bio Integrates 2021 Track 3
PROJECTION
What does the future hold for life science investment, intellect and infrastructure?
Welcome and opening remarks
Opening Remarks
MARTINO PICARDO | Chairman | Discovery Park
We are sorry that we had a few technical issues at the start of the day, so we only have the audio file of Martino’s opening remarks
A fireside chat with Andreas Wallnoefer
An interview with: ANDREAS WALLNOEFER | Partner & Investor | Jeito Capital
Interviewed by: MARTINO PICARDO | Chairman | Discovery Park
A fireside chat with Ruth McKernan CBE
An Interview with: Dr RUTH McKERNAN CBE | Neuroscientist, businesswoman and innovation leader
Interviewed by: TREVOR JONES CBE | Chairman and Board Member | e-Therapeutics, Respiratory Innovation Wales and Ascension Healthcare
Go big or go home
The Government’s Industrial Strategy and commitment to life science funding relies on companies scaling their science in the UK. How do you scale up in a fragmented ecosystem?
FACILITATED BY
DR SALLY ANN FORSYTH OBE | Chief Executive Officer | Stevenage Bioscience Catalyst
PANELLISTS INCLUDE
GLENN CROCKER MBE | Director of Ventures and Investment | We are Pioneer
JULIANNA HAGGERTY | Head of Centre of Excellence – Lipid Nanoparticles | CPI
ANDY RICHARDS CBE | Chairman | Congenica, Abcodia, Closed Loop Medicine, Arecor, Ieso Digital Health
OLIVIA DREW | Director | UBS
IRENE GRAHAM OBE | CEO | ScaleUp Institute
NICK JOHNSON | Chief Strategy Officer | Cell and Gene Therapy Catapult
Value in, value out
With a greater focus on accelerating development timelines, investors are expecting quicker returns. How can we accelerate products to deliver maximum value for patients and investors?
FACILITATED BY
KATH MACKAY | Director of Life Sciences | Bruntwood SciTech – Alderley Park
PANELLISTS INCLUDE
ANDY HILL | Chief Executive Officer | Nu-Vision Biotherapies
KOUJIRO TAMBARA | Principal | Downing
LOUWAI MUHAMMED | CEO and Co-Founder | CoSyne Therapeutics
CLARE TRIPPETT | Chief Technologist – Biologics | CPI
MARTIN DOORBAR | Chief Development Officer; Non Clinical | Ellipses
JAMIE UNWIN | Commercial Insight Officer | Nanoform
Transfer targets
Tech transfer departments in Universities are inundated with potential translational science. How do they select the projects to back?
FACILITATED BY
KEVIN COX | Chair | Biorelate
PANELLISTS INCLUDE
TOBY REID | Executive Director | We are Pioneer Group
RICH FERRIE | Chief Executive Officer | London BioInnovation Centre Ltd
SOHAIB MIR | Senior Investment Principal | LifeArc
RICHARD FAGAN | Director BioPharm | UCL Business
Preparing for the Next Pandemic
COVID-19 taught the life science industry a great deal. Now it’s time to capitalise on that knowledge. How can academia, SMEs and the government accelerate new solutions, overcome clinical, manufacturing, regulatory and commercialisation hurdles, and make sure we’re fully armed to tackle the next potential threat?
FACILITATED BY
PHIL PACKER | Innovation Lead AMR and Vaccines | Innovate UK
PANELLISTS INCLUDE
ROBIN COHEN | Chief Commercial Officer | Emergex Vaccines
DORIS-ANN WILLIAMS MBE | Chief Executive | British In Vitro Diagnostics Association (BIVDA)
SHEULI PORKESS | Vice-President & Founder and Chief Medical Officer | Faculty of Pharmaceutical Medicine & Actaros Consultancy
JANET HEMINGWAY CBE | Professor of Tropical Medicine | Liverpool School of Tropical Medicine
DAME SARAH GILBERT | Saïd Professorship of Vaccinology | Nuffield Department of Medicine, University of Oxford
Where you lead
Selecting your lead investors and assembling your syndicate is pivotal to the success of a biotech. Do you pick your investors, or do they pick you?
FACILITATED BY
NATHAN SIGWORTH | Co-founder and Chief Executive Officer | PharmaCCX
PANELLISTS INCLUDE
JENNY LAIRD | Vice President, Search & Evaluation Pain & Neurodegeneration | Eli Lilly and Company
JOLYON MARTIN | Co-Founder and Head of Business Development | PetMedix
SONIA HOUGHTON| Chief Executive Officer & Co-Founder | Cryoniss
BRADLEY HARDIMAN | Head of UK/EU Search & Evaluation | Astellas Pharmaceuticals
HAKIM YADI OBE | Co-Founder and Chief Executive | Closed Loop Medicine
Closing Remarks
MARTINO PICARDO | Chairman | Discovery Park